EUVIMEDEUVIMED entdecken
Korrektur

Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”

IUBMB Life · 2026-10 · 78 (10)

DOI: 10.1002/iub.70134 ↗

Kurz gefasst

Korrektur in der Zeitschrift IUBMB Life, online erschienen am 09.10.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”. IUBMB Life, 78(10). https://doi.org/10.1002/iub.70134

Vancouver

Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”. IUBMB Life. 2026;78(10). doi:10.1002/iub.70134

BibTeX
@article{euvimed2026,
  title = {Correction to “ MMP9 Knockout by CRISPR ‐Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti‐ PD ‐ L1 in an Orthotopic Mouse Model”},
  journal = {IUBMB Life},
  year = {2026},
  volume = {78},
  number = {10},
  doi = {10.1002/iub.70134}
}
Kostenlos starten →